These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2550258)

  • 1. Serotonergic involvement in the inhibitory effects of repeated buspirone treatment on synaptic transmission in the hippocampus.
    O'Connor JJ; Rowan MJ; Anwyl R
    Eur J Pharmacol; 1989 Aug; 167(1):21-9. PubMed ID: 2550258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The azapirone metabolite 1-(2-pyrimidinyl)piperazine depresses excitatory synaptic transmission in the hippocampus of the alert rat via 5-HT1A receptors.
    Manahan-Vaughan D; Anwyl R; Rowan MJ
    Eur J Pharmacol; 1995 Dec; 294(2-3):617-24. PubMed ID: 8750726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actions of 5-HT1 ligands on excitatory synaptic transmission in the hippocampus of alert rats.
    O'Connor JJ; Rowan MJ; Anwyl R
    Br J Pharmacol; 1990 Sep; 101(1):171-7. PubMed ID: 1980835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotoninergic depression of auditory evoked responses recorded in the rat hippocampus: effect of repeated buspirone treatment.
    O'Connor JJ; Rowan MJ; Anwyl R
    Brain Res; 1992 Feb; 573(2):190-6. PubMed ID: 1504759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT1A receptor-mediated inhibition in the hippocampus of the alert rat--effects of repeated gepirone treatment.
    Manahan-Vaughan D; Anwyl R; Rowan MJ
    Eur J Pharmacol; 1994 Aug; 260(2-3):149-55. PubMed ID: 7988638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use-dependent effects of acute and chronic treatment with imipramine and buspirone on excitatory synaptic transmission in the rat hippocampus in vivo.
    O'Connor JJ; Rowan MJ; Anwyl R
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug; 348(2):158-63. PubMed ID: 8232595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive changes in 5-HT1A receptor-mediated hippocampal inhibition in the alert rat produced by repeated 8-OH-DPAT treatment.
    Manahan-Vaughan D; Anwyl R; Rowan MJ
    Br J Pharmacol; 1994 Aug; 112(4):1083-8. PubMed ID: 7952867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-induced adaptive changes in the effects of 5-HT, 5-HT1A and 5-HT4 agonists on the population spike recorded in hippocampal CA1 cells do not involve presynaptic effects on excitatory synaptic transmission.
    Tokarski K; Bijak M
    Pol J Pharmacol; 1996; 48(6):565-73. PubMed ID: 9112695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buspirone inhibits corticotropin-releasing factor and stress-induced cecal motor response in rats by acting through 5-HT1A receptors.
    Martinez JA; Buéno L
    Eur J Pharmacol; 1991 Sep; 202(3):379-83. PubMed ID: 1748159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postsynaptic 5-HT1A receptors.
    Yocca FD
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):6S-12S. PubMed ID: 1973941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of repeated ipsapirone treatment on hippocampal excitatory synaptic transmission in the freely behaving rat: role of 5-HT1A receptors and relationship to anxiolytic effect.
    Xu L; Anwyl R; De Vry J; Rowan MJ
    Eur J Pharmacol; 1997 Mar; 323(1):59-68. PubMed ID: 9105877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buspirone attenuates synaptic activation of hippocampal pyramidal cells.
    Mauk MD; Peroutka SJ; Kocsis JD
    J Neurosci; 1988 Jan; 8(1):1-11. PubMed ID: 3339401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced defaecation in rats: role of central 5-HT1A receptors.
    Croci T; Landi M; Bianchetti A; Manara L
    Br J Pharmacol; 1995 May; 115(1):203-9. PubMed ID: 7647978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic modulation of neurotransmission in the rat basolateral amygdala.
    Rainnie DG
    J Neurophysiol; 1999 Jul; 82(1):69-85. PubMed ID: 10400936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability.
    Hiner BC; Mauk MD; Peroutka SJ; Kocsis JD
    Brain Res; 1988 Sep; 461(1):1-9. PubMed ID: 2906267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short- and long-term administration of 5-hydroxytryptamine1A agonist and antidepressants.
    Newman ME; Shapira B; Lerer B
    J Pharmacol Exp Ther; 1992 Jan; 260(1):16-20. PubMed ID: 1530973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.